119 related articles for article (PubMed ID: 10675722)
1. Proteases in gastrointestinal neoplastic diseases.
Herszényi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Cardin R; Foschia F; Tulassay Z; Naccarato R; Farinati F
Clin Chim Acta; 2000 Feb; 291(2):171-87. PubMed ID: 10675722
[TBL] [Abstract][Full Text] [Related]
2. [The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer].
Herszényi L; Farinati F; Plebani M; István G; Sápi Z; Carraro P; De Paoli M; Naccarato R; Tulassay Z
Orv Hetil; 1999 Aug; 140(33):1833-6. PubMed ID: 10489782
[TBL] [Abstract][Full Text] [Related]
3. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers.
Herszényi L; István G; Cardin R; De Paoli M; Plebani M; Tulassay Z; Farinati F
Eur J Cancer Prev; 2008 Oct; 17(5):438-45. PubMed ID: 18714186
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic role of cisteine and serin proteases in gastriC cancer].
Herszényi L; Farinati F; Plebani M; Carraro P; Roveroni G; De Paoli M; Cardin R; Naccarato R; Tulassay Z
Orv Hetil; 1996 Jul; 137(30):1637-41. PubMed ID: 9019701
[TBL] [Abstract][Full Text] [Related]
5. The role of urokinase-type plasminogen activator and its inhibitor PAI-1 in gastric cancer.
Herszényi L; Plebani M; Cardin R; Carraro P; De Paoli M; Roveroni G; Naccarato R; Farinati F
Acta Physiol Hung; 1995; 83(3):213-21. PubMed ID: 8852646
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the role of proteases in cancer.
Koblinski JE; Ahram M; Sloane BF
Clin Chim Acta; 2000 Feb; 291(2):113-35. PubMed ID: 10675719
[TBL] [Abstract][Full Text] [Related]
8. Tumour-associated fibrinolysis: the prognostic relevance of plasminogen activators uPA and tPA in human breast cancer.
Schmitt M; Jänicke F; Graeff H
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):695-702. PubMed ID: 2133250
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract][Full Text] [Related]
11. FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
Goscinski MA; Suo Z; Flørenes VA; Vlatkovic L; Nesland JM; Giercksky KE
Ultrastruct Pathol; 2008; 32(3):89-96. PubMed ID: 18570153
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value.
Hundsdorfer B; Zeilhofer HF; Bock KP; Dettmar P; Schmitt M; Kolk A; Pautke C; Horch HH
J Craniomaxillofac Surg; 2005 Jun; 33(3):191-6. PubMed ID: 15878520
[TBL] [Abstract][Full Text] [Related]
13. Protease levels in breast, ovary, and other gynecological tumor tissues: prognostic importance in breast cancer.
Ruppert C; Ehrenforth S; Scharrer I; Halberstadt E
Cancer Detect Prev; 1997; 21(5):452-9. PubMed ID: 9307848
[TBL] [Abstract][Full Text] [Related]
14. High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma.
Cho JY; Chung HC; Noh SH; Roh JK; Min JS; Kim BS
Cancer; 1997 Mar; 79(5):878-83. PubMed ID: 9041148
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and prognostic significance of tumor-associated proteases in gynecologic oncology].
Graeff H; Jänicke F; Schmitt M
Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):90-9. PubMed ID: 2040418
[TBL] [Abstract][Full Text] [Related]
18. Proteases associated with gynecological tumors.
Ruppert C; Ehrenforth S; Tutschek B; Vering A; Beckmann M; Scharrer I; Bender H
Int J Oncol; 1994 Mar; 4(3):717-21. PubMed ID: 21566982
[TBL] [Abstract][Full Text] [Related]
19. Strong prognostic impact of tumor-associated urokinase-type plasminogen activator in completely resected adenocarcinoma of the esophagus.
Nekarda H; Schlegel P; Schmitt M; Stark M; Mueller JD; Fink U; Siewert JR
Clin Cancer Res; 1998 Jul; 4(7):1755-63. PubMed ID: 9676852
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis.
Fuessel S; Erdmann K; Taubert H; Lohse-Fischer A; Zastrow S; Meinhardt M; Bluemke K; Hofbauer L; Fornara P; Wullich B; Baretton G; Magdolen V; Wirth MP; Kotzsch M
BMC Cancer; 2014 Dec; 14():974. PubMed ID: 25519168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
